References
- Kosmidis, P.; Mylonakis, N.; Nicolaides, C.; Kalophonos, C.; Samantas, E.; , et al. Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial.J. Clin. Oncol. 2002, 20 (17), 3578–3585. [PUBMED], [INFOTRIEVE], [CSA]
- Rosell, R.; Gatzemeier, U.; Betticher, D C.; Keppler, U.; Macha, H N.; , et al. Phase III randomized trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial.Ann. Oncol. 2002, 13 (10), 1539–1549. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Manegold, C. Chemotherapy for advanced non-small cell lung cancer: standards.Lung Cancer 2001, 34 (Suppl. 2), S165–S170. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Stupp, R.; Bodmer, A.; Duvoisin, B.; Bauer, J.; Perey, L.; , et al. Is cisplatin required for the treatment of non-small-cell lung cancer? Experience and preliminary results of a phase I/II trial with topotecan and vinorelbine.Oncology 2001, 61 (Suppl. 1), 35–41. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zhou, X J.; Rahmani, R. Preclinical and clinical pharmacology of vinca alkaloids.Drugs 1992, 44 (Suppl. 4), 1–16. [PUBMED], [INFOTRIEVE], [CSA]
- Binet, S.; Chaineau, E.; Fellous, A.; Lataste, H.; Krikorian, A.; Couzinier, J P.; Meininger, V. Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubules.Int. J. Cancer 1990, 46 (2), 262–266. [PUBMED], [INFOTRIEVE], [CSA]
- Abal, M.; Andreu, J M.; Barasoain, I. Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action.Curr. Cancer Drug Targets 2003, 3 (3), 193–203. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Depierre, A.; Lemarie, E.; Dabouis, G.; Garnier, G.; Jacoulet, P.; Dalphin, J C. Efficacy of navelbine (NVB) in non-small cell lung cancer (NSCLC).Semin. Oncol. 1989, 16 (2 Suppl. 4), 26–29. [PUBMED], [INFOTRIEVE], [CSA]
- Rowinsky, E K.; Onetto, N.; Canetta, R M.; Arbuck, S G. Taxol: the first of the taxanes, an important new class of antitumor agents.Semin. Oncol. 1992, 19 (6), 646–662. [PUBMED], [INFOTRIEVE], [CSA]
- Knick, V C.; Eberwein, D J.; Miller, C G. Vinorelbine tartrate and paclitaxel combinations: enhanced activity against in vivo P388 murine leukemia cells.J. Natl. Cancer Inst. 1995, 87 (14), 1072–1077. [PUBMED], [INFOTRIEVE], [CSA]
- Miller, A B.; Hoogstraten, B.; Staquet, M.; Winkler, A. Reporting results of cancer treatment.Cancer 1981, 47 (1), 207–214. [PUBMED], [INFOTRIEVE], [CSA]
- Ginopoulos, P.; Kontomanolis, E.; Kardamakis, D.; Sougleri, M.; Rathosis, S.; , et al. A phase II study of non-platinum based chemotherapy with paclitaxel and vinorelbine in non-small cell lung cancer.Lung Cancer 2002, 38 (2), 199–203. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Perez, J E.; Machiavelli, M R.; Romero, A O.; Romero Acuna, L A.; , et al. Vinorelbine and paclitaxel for locoregional advanced or metastatic non-small-cell lung cancer.Am. J. Clin. Oncol. 2002, 25 (4), 383–387. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Schiller, J H.; Harrington, D.; Belani, C P.; Langer, C.; Sandler, A.; ; Eastern Cooperative Oncology Group, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.N. Engl. J. Med. 2002, 346 (2), 92–98. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Retsas, S.; Mohith, A.; Mackenzie, H. Taxol and vinorelbine: a new active combination for disseminated malignant melanoma.Anti-cancer Drugs 1996, 7 (2), 161–165. [PUBMED], [INFOTRIEVE], [CSA]
- Budman, D R.; Calabro, A.; Wang, L G.; Liu, X M.; Stiel, L.; Adams, L M.; Kreis, W. Synergism of cytotoxic effects of vinorelbine and paclitaxel in vitro.Cancer Investig. 2000, 18 (8), 695–701. [CSA]
- Culine, S.; Roch, I.; Pinguet, F.; Romieu, G.; Bressolle, F. Combination paclitaxel and vinorelbine therapy: in vitro cytotoxic interactions and dose-escalation study in breast cancer patients previously exposed to anthracyclines.Int. J. Oncol. 1999, 14 (5), 999–1006. [PUBMED], [INFOTRIEVE], [CSA]
- Kano, Y.; Akutsu, M.; Suzuki, K.; Ando, J.; Tsunoda, S. Schedule-dependent interactions between vinorelbine and paclitaxel in human carcinoma cell lines in vitro.Breast Cancer Res. Treat. 1999, 56 (1), 79–90. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jung, M.; Grunberg, S.; Timblin, C.; Buder-Hoffman, S.; , et al. Paclitaxel and vinorelbine cause synergistic increases in apoptosis but not in microtubular disruption in human lung adenocarcinoma cells (A-549).Histochem. Cell Biol. 2004, 121 (2), 115–121. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cohen, R B.; Mueller, S C.; Haden, K.; de Souza, P. Phase I study of weekly vinorelbine in combination with weekly paclitaxel in adult patients with advanced refractory cancer.Cancer Investig. 2000, 18 (5), 422–428. [CSA]
- Perry, M C.; Ihde, D C.; Herndon, J E.; Grossbard, M L.; Grethein, S J.; Atkins, J N. Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532.Lung Cancer 2000, 28 (1), 63–68. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Budman, D R.; Weiselberg, L.; O'Mara, V.; Buchbinder, A.; Lichtman, S M.; Donahue, L. A phase I study of sequential vinorelbine followed by paclitaxel.Ann. Oncol. 1999, 10 (7), 861–863. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Aoe, K.; Kiura, K.; Ueoka, H.; Tabata, M.; Matsumura, T.; Chikamori, M. Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines.Anticancer Res. 1999, 19 (1A), 291–299. [PUBMED], [INFOTRIEVE], [CSA]
- Bennouna, J.; Monnier, A.; Riviere, A.; Milleron, B.; Lemarie, E.; Trillet-Lenoir, V. A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancer.Eur. J. Cancer 2000, 36 (9), 1107–1112. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Miller, V A.; Krug, L M.; Ng, K K.; Pizzo, B.; Oerez, W.; Heelan, R T. Phase II trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer.J. Clin. Oncol. 2000, 18 (6), 1346–1350. [PUBMED], [INFOTRIEVE], [CSA]
- Wang, L G.; Liu, X M.; Kreis, W.; Budman, D R. The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review.Cancer Chemother. Pharmacol. 1999, 44 (5), 355–361. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Krug, L M.; Miller, V A.; Filippa, D A.; Venkatraman, E.; Ng, K K.; Kris, M G. Bcl-2 and bax expression in advanced non-small cell lung cancer: lack of correlation with chemotherapy response or survival in patients treated with docetaxel plus vinorelbine.Lung Cancer 2003, 39 (2), 139–143. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]